Tisotumab Vedotin As Second- or Third-Line Therapy for Recurrent Cervical Cancer
Ignace Vergote,Antonio Gonzalez-Martin,Keiichi Fujiwara,Elsa Kalbacher, Andrea Bagameri,Sharad Ghamande,Jung-Yun Lee,Susana Banerjee,Fernando Cotait Maluf,Domenica Lorusso,Kan Yonemori,Els Van Nieuwenhuysen,Luis Manso,Linn Woelber,Anneke Westermann,Allan Covens,Kosei Hasegawa,Byoung-Gie Kim, Miriam Raimondo,Maria Bjurberg,Felipe Melo Cruz,Antoine Angelergues,David Cibula,Lisa Barraclough,Ana Oaknin,Christine Gennigens, Leo Nicacio, Melinda Siew Leng Teng, Elizabeth Whalley,Ibrahima Soumaoro,Brian M. Slomovitz NEW ENGLAND JOURNAL OF MEDICINE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper